Lemaitre Vascular (LMAT) Tops Q2 EPS by 5c, Beats on Revenue; Offers FY24 Guidance
Tweet
Share
E-mailGet Alerts LMAT Hot Sheet
Price: $83.35 +1.02%
Financial Fact:
Cash dividends declared per common share: 0.05
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Cash dividends declared per common share: 0.05
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Lemaitre Vascular (NASDAQ: LMAT) reported Q2 EPS of $0.52, $0.05 better than the analyst estimate of $0.47. Revenue for the quarter came in at $55.8 million versus the consensus estimate of $54.98 million.
GUIDANCE:
Lemaitre Vascular sees FY2024 EPS of $1.82-$1.91, versus the consensus of $1.77. Lemaitre Vascular sees FY2024 revenue of $216.8-220.8 million, versus the consensus of $215 million.
For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Uber sells part of its Aurora stake in block trade - Bloomberg
- Rockwell Medical Technologies (RMTI) PT Lowered to $20 at Maxim Group
- Amylyx Pharmaceuticals (AMLX) 19K contracts trade
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
